Cargando…

Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV

PURPOSE: Liver-related comorbidities can impair the health-related quality of life (HRQL) in people living with human immunodeficiency virus (HIV) (PLWH). However, the role of hepatic steatosis and significant fibrosis in PLWH remains incompletely characterized. Therefore, the aim of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Michel, Maurice, Wahl, Alisha, Anders, Malena, Alqahtani, Saleh A., Kremer, Wolfgang M., Galle, Peter R., Labenz, Christian, Grimm, Daniel, Sprinzl, Martin, Schattenberg, Jörn M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911489/
https://www.ncbi.nlm.nih.gov/pubmed/35996039
http://dx.doi.org/10.1007/s11136-022-03232-w
_version_ 1784885000517189632
author Michel, Maurice
Wahl, Alisha
Anders, Malena
Alqahtani, Saleh A.
Kremer, Wolfgang M.
Galle, Peter R.
Labenz, Christian
Grimm, Daniel
Sprinzl, Martin
Schattenberg, Jörn M.
author_facet Michel, Maurice
Wahl, Alisha
Anders, Malena
Alqahtani, Saleh A.
Kremer, Wolfgang M.
Galle, Peter R.
Labenz, Christian
Grimm, Daniel
Sprinzl, Martin
Schattenberg, Jörn M.
author_sort Michel, Maurice
collection PubMed
description PURPOSE: Liver-related comorbidities can impair the health-related quality of life (HRQL) in people living with human immunodeficiency virus (HIV) (PLWH). However, the role of hepatic steatosis and significant fibrosis in PLWH remains incompletely characterized. Therefore, the aim of this study was to explore the association of hepatic steatosis and significant fibrosis on the HRQL using the medical outcomes study HIV health survey (MOS-HIV) in PLWH. METHODS: A total of 222 PLWH were included in the final analysis of this cohort study. Metabolic comorbidities, socioeconomic factors, and HIV-related parameters were assessed. Hepatic steatosis and fibrosis were measured using vibration-controlled transient elastography (VCTE). The MOS-HIV survey, containing two summary scores (physical health summary (PHS) and mental health summary (MHS)) and ten domains, was used to assess the HRQL. Clinical predictors were identified using multivariable linear regression models. RESULTS: The majority of this cohort was male, and the median age was 52 years, with a high prevalence of hepatic steatosis (n = 81, 36.5%). Significant fibrosis was present in 7.7% (n = 17). The mean PHS and MHS scores were 52.7 ± 9.5 and 51.4 ± 10.5, respectively. The lowest scores were in the general health perception (GHP) and energy/fatigue (EF) domains. A high BMI and waist circumference were associated with a poor PHS score. Lower education, unemployment, arterial hypertension, and significant fibrosis remained independent predictors of an impaired HRQL. CONCLUSION: Metabolic comorbidities, significant fibrosis, and a lower socioeconomic status may negatively affect the HRQL in PLWH. Considering the negative impact of significant fibrosis on the outcome, counseling and preventive measures according to current guidelines are recommended in this subgroup of PLWH. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11136-022-03232-w.
format Online
Article
Text
id pubmed-9911489
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-99114892023-02-11 Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV Michel, Maurice Wahl, Alisha Anders, Malena Alqahtani, Saleh A. Kremer, Wolfgang M. Galle, Peter R. Labenz, Christian Grimm, Daniel Sprinzl, Martin Schattenberg, Jörn M. Qual Life Res Article PURPOSE: Liver-related comorbidities can impair the health-related quality of life (HRQL) in people living with human immunodeficiency virus (HIV) (PLWH). However, the role of hepatic steatosis and significant fibrosis in PLWH remains incompletely characterized. Therefore, the aim of this study was to explore the association of hepatic steatosis and significant fibrosis on the HRQL using the medical outcomes study HIV health survey (MOS-HIV) in PLWH. METHODS: A total of 222 PLWH were included in the final analysis of this cohort study. Metabolic comorbidities, socioeconomic factors, and HIV-related parameters were assessed. Hepatic steatosis and fibrosis were measured using vibration-controlled transient elastography (VCTE). The MOS-HIV survey, containing two summary scores (physical health summary (PHS) and mental health summary (MHS)) and ten domains, was used to assess the HRQL. Clinical predictors were identified using multivariable linear regression models. RESULTS: The majority of this cohort was male, and the median age was 52 years, with a high prevalence of hepatic steatosis (n = 81, 36.5%). Significant fibrosis was present in 7.7% (n = 17). The mean PHS and MHS scores were 52.7 ± 9.5 and 51.4 ± 10.5, respectively. The lowest scores were in the general health perception (GHP) and energy/fatigue (EF) domains. A high BMI and waist circumference were associated with a poor PHS score. Lower education, unemployment, arterial hypertension, and significant fibrosis remained independent predictors of an impaired HRQL. CONCLUSION: Metabolic comorbidities, significant fibrosis, and a lower socioeconomic status may negatively affect the HRQL in PLWH. Considering the negative impact of significant fibrosis on the outcome, counseling and preventive measures according to current guidelines are recommended in this subgroup of PLWH. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11136-022-03232-w. Springer International Publishing 2022-08-22 2023 /pmc/articles/PMC9911489/ /pubmed/35996039 http://dx.doi.org/10.1007/s11136-022-03232-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Michel, Maurice
Wahl, Alisha
Anders, Malena
Alqahtani, Saleh A.
Kremer, Wolfgang M.
Galle, Peter R.
Labenz, Christian
Grimm, Daniel
Sprinzl, Martin
Schattenberg, Jörn M.
Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV
title Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV
title_full Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV
title_fullStr Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV
title_full_unstemmed Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV
title_short Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV
title_sort significant liver fibrosis is a predictor of poor health-related quality of life in people living with hiv
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911489/
https://www.ncbi.nlm.nih.gov/pubmed/35996039
http://dx.doi.org/10.1007/s11136-022-03232-w
work_keys_str_mv AT michelmaurice significantliverfibrosisisapredictorofpoorhealthrelatedqualityoflifeinpeoplelivingwithhiv
AT wahlalisha significantliverfibrosisisapredictorofpoorhealthrelatedqualityoflifeinpeoplelivingwithhiv
AT andersmalena significantliverfibrosisisapredictorofpoorhealthrelatedqualityoflifeinpeoplelivingwithhiv
AT alqahtanisaleha significantliverfibrosisisapredictorofpoorhealthrelatedqualityoflifeinpeoplelivingwithhiv
AT kremerwolfgangm significantliverfibrosisisapredictorofpoorhealthrelatedqualityoflifeinpeoplelivingwithhiv
AT gallepeterr significantliverfibrosisisapredictorofpoorhealthrelatedqualityoflifeinpeoplelivingwithhiv
AT labenzchristian significantliverfibrosisisapredictorofpoorhealthrelatedqualityoflifeinpeoplelivingwithhiv
AT grimmdaniel significantliverfibrosisisapredictorofpoorhealthrelatedqualityoflifeinpeoplelivingwithhiv
AT sprinzlmartin significantliverfibrosisisapredictorofpoorhealthrelatedqualityoflifeinpeoplelivingwithhiv
AT schattenbergjornm significantliverfibrosisisapredictorofpoorhealthrelatedqualityoflifeinpeoplelivingwithhiv